GenVec - GNVC Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GenVec - GNVC

GNVC 7.193

0.0%

Jun 26 4:00 PM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Savant who wrote (91)	12/1/2016 1:01:25 PM
From: Gary Mohilner	Read Replies (1) of 106

Hopefully GNVC is now positioned to move dramatically on any positive news. I believe that the hearing trials will take years, and probably will require the supplemental drug GNVC is developing to be truly effective, but approval could come from less than limited hearing improvement. GNVC is now down to well under 10 million shares, as I remember it. They almost certainly will do dilutive funding in the future, but as I remember it, their limits are still under 100 million shares. Success on the h earing or other products they have in development could easily take their market cap to well in excess of a billion which would finally turn this investment profitable. Gary

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next